Eikon Therapeutics Files for IPO Led By Merck Veterans
Summarize this article with:
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000US Stocks:Eikon Therapeutics Inc. filed for an initial public offering to help fund its advanced pipeline of cancer drugs.The company plans for its shares to trade on the Nasdaq Global Market under the symbol EIKN, according to a filing Friday with the US Securities and Exchange Commission. JPMorgan Chase & Co., Morgan Stanley, Bank of America Corp and Cantor Fitzgerald are working on the offering.